Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
Today the International Narcotics Control Board (INCB) released its annual report. I’ve been following the Board for many, many years now, have often criticized its narrow interpretation of the treaties, have questioned the validity of its usually negative comments about any policy changes in the direction of harm reduction or decriminalization, and have warned repeatedly about its tendency to overstep its clearly defined mandate.
Recently, the UNODC has begun to take notice of the impact of its counternarcotics work on human rights. Antonio Maria Costa, the current executive director, has set out a series of recommendations for internal reform intended to improve the agency's human rights performance. This leadership on human rights is very welcome, and much needed, but it may already be under threat. Costa leaves his post at the end of July. Unfortunately, the current frontrunner for the role of UN drug tsar is the candidate being pushed by the Russian government.